News for 'Viral Research'

Scientists develop new method to block coronavirus replication

Scientists develop new method to block coronavirus replication

Rediff.com17 Oct 2020

The researchers, including those from the University of Texas Health Science Center at San Antonio (UT Health San Antonio) in the United States, developed two molecules that inhibit the molecular 'scissor' enzyme used by the coronavirus called SARS-CoV-2-PLpro.

3 Covid waves likely to hit China in the coming months

3 Covid waves likely to hit China in the coming months

Rediff.com21 Dec 2022

It is certain that the Chinese government was 'under-prepared' as it decided to end its zero-COVID policy abruptly after people held protests across the country, The Hong Kong Post reported.

India records 16,838 new COVID-19 cases, 113 fatalities

India records 16,838 new COVID-19 cases, 113 fatalities

Rediff.com5 Mar 2021

India's COVID-19 tally has climbed to 1,11,73,761 with 16,838 fresh cases reported in a day, while the number of patients who have recuperated from the disease has surged to 1,08,39,894, the Union health ministry said on Friday.

India reports 1,660 new Covid cases, 4,100 deaths in 24 hrs

India reports 1,660 new Covid cases, 4,100 deaths in 24 hrs

Rediff.com26 Mar 2022

A total of 1,660 fresh cases have pushed the country's COVID-19 tally to 4,30,18,032, while the number of active cases has fallen below 20,000, according to the ministry's data updated at 8 am.

COVID: India records 14,849 fresh cases, 155 more fatalities

COVID: India records 14,849 fresh cases, 155 more fatalities

Rediff.com24 Jan 2021

The active COVID-19 caseload of the country remained below two lakh for the fifth consecutive day.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.

How monkeys were tracked for Covaxin trial

How monkeys were tracked for Covaxin trial

Rediff.com14 Nov 2021

The Rhesus macaque monkeys, used worldwide in medical research, are believed to be the best non-human primates for such studies.

India records 13,083 fresh COVID-19 cases, 137 fatalities

India records 13,083 fresh COVID-19 cases, 137 fatalities

Rediff.com30 Jan 2021

With 13,083 fresh cases, India's COVID-19 tally has gone up to 1,07,33,131, while 1,04,09,160 patients have recuperated so far, pushing the national recovery rate to 96.98 per cent, the health ministry said.

India reports 67 Covid deaths in 24 hrs, active cases above 1.5 lakh

India reports 67 Covid deaths in 24 hrs, active cases above 1.5 lakh

Rediff.com23 Jul 2022

India's COVID-19 tally climbed to 4,38,68,476 on Saturday with 21,411 fresh cases, while the number of active cases increased to 1,50,100, according to Union health ministry data.

India's Covid tally climbs to 1,12,44,786

India's Covid tally climbs to 1,12,44,786

Rediff.com9 Mar 2021

The death toll due to the viral disease has gone up to 1,57,930 in the country with 77 more fatalities, the ministry's data updated at 8 am showed.

New COVID-19 test can give results in just 45 minutes

New COVID-19 test can give results in just 45 minutes

Rediff.com29 Apr 2020

The test named the "SARS-CoV-2 DETECTR" is easy to implement and to interpret, and requires no specialised equipment, said researchers from the University of California, San Francisco in the US.

Nasal rinsing, gargling could aid in fighting COVID-19

Nasal rinsing, gargling could aid in fighting COVID-19

Rediff.com6 May 2020

The report in international health journal 'Lung India' published on Tuesday points out the significance of nasal rinsing and gargling with saline water in preventing the contract of the virus in the present scenario when the world is reeling under the COVID-19 pandemic.

Coronavirus can survive on skin for 9 hours: Study

Coronavirus can survive on skin for 9 hours: Study

Rediff.com9 Oct 2020

The finding underscores the importance of hand washing or using a sanitiser to prevent the spread of COVID-19.

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

Rediff.com28 Jun 2022

The DCGI's nod came after the subject expert committee on COVID-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax for the age group of 7 to 11 years.

India records highest single-day Covid deaths at 1,341

India records highest single-day Covid deaths at 1,341

Rediff.com17 Apr 2021

The number of active coronavirus cases in the country has surpassed the 16-lakh mark, the ministry's data updated at 8 am showed.

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

Rediff.com14 Apr 2021

The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.

Six feet gap not enough to prevent virus spread, says study

Six feet gap not enough to prevent virus spread, says study

Rediff.com15 Sep 2021

Physical distancing of two metres - about six and a half feet - may not be enough to sufficiently prevent transmission of virus-carrying airborne aerosols indoors, says a study.

Covid 3rd wave unlikely to be as severe as second: Study

Covid 3rd wave unlikely to be as severe as second: Study

Rediff.com25 Jun 2021

A third wave of COVID-19 -- if it occurs -- is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study.

India logs 2,858 new Covid infections, 11 deaths; active cases drop

India logs 2,858 new Covid infections, 11 deaths; active cases drop

Rediff.com14 May 2022

The active cases comprise 0.04 per cent of the total infections. The national COVID-19 recovery rate was recorded at 98.74 per cent, the ministry said.

Zwigato Review: Kapil Sharma's Wow Performance!

Zwigato Review: Kapil Sharma's Wow Performance!

Rediff.com17 Mar 2023

A far cry from his playing-to-the-gallery comedian, Kapil Sharma emerges as a heartfelt picture of aspiration and annoyance, feels Sukanya Verma.

India records over 13,000 Covid cases after 113 days

India records over 13,000 Covid cases after 113 days

Rediff.com18 Jun 2022

The number of people who have recuperated from the disease surged to 4,26,90,845.

Why Is It An Attack On India?

Why Is It An Attack On India?

Rediff.com7 Feb 2023

India's Right-wing has sought to own our democracy by making itself appear the stuff of majority, and sometimes, a national ethos older than the Constitution on which our democracy is based, argues Shyam G Menon.

67% have Covid antibodies, another 40 cr still vulnerable to infection: Govt

67% have Covid antibodies, another 40 cr still vulnerable to infection: Govt

Rediff.com20 Jul 2021

Findings of the Indian Council of Medical Research's fourth national Covid sero survey show there is a ray of hope, but there is no room for complacency and Covid-appropriate behaviour has to be followed, the government said.

Ranchi girl mistakenly informed she cracked UPSC, family apologises

Ranchi girl mistakenly informed she cracked UPSC, family apologises

Rediff.com4 Jun 2022

The family of Divya Pandey, 24, who claimed she had cracked the civil services examination in her maiden attempt, on Friday apologised to the district administration and Central Coalfields Ltd (CCL), both of which felicitated her, as well as the media for furnishing erroneous information of her success and said it was an 'inadvertent error'.

India sees 2,338 Covid cases, active tally at 17,883

India sees 2,338 Covid cases, active tally at 17,883

Rediff.com31 May 2022

The number of people who have recuperated from the disease surged to 4,26,15,574.

DRDO's Covid drug: Benefits. Concerns

DRDO's Covid drug: Benefits. Concerns

Rediff.com31 May 2021

Commercial launch and supply to major government and private hospitals is expected in mid-June.

India reports over 1.45 lakh new COVID-19 cases in 24 hrs

India reports over 1.45 lakh new COVID-19 cases in 24 hrs

Rediff.com10 Apr 2021

With a record 1,45,384 fresh cases, India's COVID-19 tally has climbed to 1,32,05,926, the health ministry said.

Active Covid cases in India continue to rise with 975 new infections

Active Covid cases in India continue to rise with 975 new infections

Rediff.com16 Apr 2022

India's COVID-19 tally climbed to 4,30,40,947 on Saturday with 975 more people testing positive for the viral disease, while the active cases increased to 11,366, according to Union health ministry data.

Rapid antigen tests are spuriously comforting: Scientists

Rapid antigen tests are spuriously comforting: Scientists

Rediff.com11 Sep 2020

'There are not enough RT-PCR tests and they take a long time to do in specialised centres. So the world is using RA tests for the same reason that India is using them, and with similar somewhat spuriously comforting rationale'

India records 1,054 fresh Covid infections, 29 deaths; active cases drop

India records 1,054 fresh Covid infections, 29 deaths; active cases drop

Rediff.com10 Apr 2022

The active cases account for 0.03 per cent of the total caseload, while the national COVID-19 recovery rate remained at 98.76 per cent, the ministry said.

Covid-19 could be the boost Indian pharma cos need

Covid-19 could be the boost Indian pharma cos need

Rediff.com20 Sep 2020

The western world had largely considered India to be a production hub, and also, a good potential geography for clinical trials, and a big market. But in Covid-19 research, Indian companies and government researchers are also researching new drug candidates and potential vaccines, says Prosenjit Datta.

India records 309 Omicron cases in 24 hrs, count rises to 1,270

India records 309 Omicron cases in 24 hrs, count rises to 1,270

Rediff.com31 Dec 2021

It also recorded 16,764 fresh COVID-19 cases and 220 more fatalities due to the viral disease.

Distancing, face mask could help avoid second COVID-19 wave: Study

Distancing, face mask could help avoid second COVID-19 wave: Study

Rediff.com23 Jun 2020

The findings, published in the journal Nature Human Behaviour, also show that, in countries that have not yet reached the peak of active cases, lockdowns must remain in place for at least 60 days and deconfinement must be gradual in order to decrease the risk of second waves.

India records 3.66 lakh fresh Covid cases, 3,754 deaths

India records 3.66 lakh fresh Covid cases, 3,754 deaths

Rediff.com10 May 2021

The number of active cases of the coronavirus infection in the country has gone up to 37,45,237, accounting for 16.53 per cent of its total caseload, while the national COVID-19 recovery rate was recorded at 82.39 per cent.

Coronavirus mutations may not make it more infectious: Study

Coronavirus mutations may not make it more infectious: Study

Rediff.com26 May 2020

Coronaviruses, like other RNA viruses, can develop mutations in three different ways: by mistake from copying errors during viral replication, through interactions with other viruses infecting the same cell, or they can be induced by RNA modification systems which are part of host immunity, the researchers explained.

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Monkeypox: Experts allay fears, say disease less contagious and rarely fatal

Rediff.com24 Jul 2022

According to these experts, a monkeypox outbreak can effectively be tackled by strong surveillance.

A mask that can deactivate COVID-19

A mask that can deactivate COVID-19

Rediff.com8 Jul 2020

'If people use the mask properly, we can confidently say that this is as protective as the best mask in the market.'<

India forms monkeypox taskforce after patient's death

India forms monkeypox taskforce after patient's death

Rediff.com1 Aug 2022

A 22-year-old man, who recently returned to Kerala from the UAE, allegedly died due to monkeypox on Saturday.

Indian scientists develop low-cost COVID-19 test, Feluda

Indian scientists develop low-cost COVID-19 test, Feluda

Rediff.com22 Apr 2020

Named after 'Feluda', the detective character in legendary filmmaker Satyajit Ray's stories, the test has been developed by Debojyoti Chakraborty and Souvik Maiti as a simpler way of detecting SARS-coV2 presence in clinical samples, IGIB Director Anurag Agarwal said.

Anti-Covid drug developed by DRDO cleared for emergency use

Anti-Covid drug developed by DRDO cleared for emergency use

Rediff.com8 May 2021

It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.